Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases — Katarzyna Kaziród (2022) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Shared by
Jozef Dulak
Jagiellonian University Cracow
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Article
2022
en
Authors
+1 more
KK
Katarzyna Kaziród
MM
Małgorzata Myszka
Jozef Dulak
Jagiellonian University Cracow
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2024
432P Hydrogen sulfide attenuates skeletal muscle abnormalities in a murine model of Duchenne muscular dystrophy
Agnieszka Łoboda
,
Małgorzata Myszka
,
Olga Mucha
,
Kalina Hajok
,
Ewa Jakubczak
,
Urszula Waśniowska
,
Jozef Dulak
Article
2024
Cardioprotective Effects of Hydrogen Sulfide and Its Potential Therapeutic Implications in the Amelioration of Duchenne Muscular Dystrophy Cardiomyopathy
Agnieszka Łoboda
,
Jozef Dulak
Article
2020
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Agnieszka Łoboda
,
Jozef Dulak
Article
2021
Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
Olga Mucha
,
Paulina Podkalicka
,
Katarzyna Kaziród
,
Emilia Samborowska
,
Jozef Dulak
,
Agnieszka Łoboda
Article
2025
Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies
Agnieszka Łoboda
,
Jozef Dulak
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.